NCT03070392 2026-03-17Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal MelanomaImmunocore LtdPhase 2 Completed378 enrolled 15 charts 1 FDA
NCT01712490 2026-02-27A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin LymphomaTakedaPhase 3 Completed1,334 enrolled 23 charts